The present invention relates generally to systems and methods for effecting non-standard fluid line connections.
Intravascular catheters have been introduced for controlling patient temperature. Typically, a coolant such as saline is circulated through an intravascular heat exchange catheter, which is positioned in the patient's bloodstream, to cool or heat the blood as appropriate for the patient's condition. The coolant is warmed or cooled by a computer-controlled heat exchanger that is external to the patient and that is in fluid communication with the catheter.
For example, intravascular heat exchange catheters can be used to combat potentially harmful fever in patients suffering from neurological and cardiac conditions such as stroke, subarachnoid hemorrhage, intracerebral hemorrhage, cardiac arrest, and acute myocardial infarction, or to induce therapeutic hypothermia in such patients. Further, such catheters can be used to rewarm patients after, e.g., cardiac surgery or for other reasons such as keeping patients warm during skin graft surgery. Intravascular catheters afford advantages over external methods of cooling and warming, including more precise temperature control and more convenience on the part of medical personnel.
The following U.S. patents, all of which are incorporated herein by reference, disclose various intravascular catheters/systems/methods: U.S. Pat. Nos. 6,419,643, 6,416,533, 6,409,747, 6,405,080, 6,393,320, 6,368,304, 6,338,727, 6,299,599, 6,290,717, 6,287,326, 6,165,207, 6,149,670, 6,146,411, 6,126,684, 6,306,161, 6,264,679, 6,231,594, 6,149,676, 6,149,673, 6,110,168, 5,989,238, 5,879,329, 5,837,003, 6,383,210, 6,379,378, 6,364,899, 6,325,818, 6,312,452, 6,261,312, 6,254,626, 6,251,130, 6,251,129, 6,245,095, 6,238,428, 6,235,048, 6,231,595, 6,224,624, 6,149,677, 6,096,068, 6,042,559.
As critically recognized herein, a need exists to effect fluid line connections in medical devices such as the catheters described above to avoid unintentionally connecting a component such as a syringe having a standard connector such as a standard Luer fitting with a connector leading to a lumen that is not intended to receive the fluid in the component.
A medical fluid connector system includes a unitary male connector body defining an inner hollow male cone and an outer annular sleeve surrounding the male cone and radially spaced from the cone. The sleeve is internally threaded and the male cone extends axially beyond the sleeve. The body includes structure that prevents engaging a standard female Luer fitting with the body.
The structure which prevents engagement with a standard female Luer can include an outer diameter of the male cone that is greater than an outer diameter of a male cone of a standard male Luer fitting. In addition or alternatively, the structure can include an inner diameter of the sleeve that is greater than an inner diameter of a sleeve of a standard male Luer fitting. Yet again, in addition or as an alternative the structure may include a thread pitch of the sleeve that is greater than a thread pitch of a sleeve of a standard male Luer fitting.
A unitary female connector body may also provided which defines a female cone having an external radially elongated triangular thread configured for engaging the threads of the sleeve.
In another aspect, a medical fluid connector system includes a unitary female connector body defining a female cone having an external radially elongated triangular thread configured for engaging threads of a sleeve of a male connector body.
In still another aspect, a method includes providing a male connector having a central hollow male cone spaced from an annular surrounding internally threaded sleeve. The method further includes providing a female connector having a female cone with a radially elongated triangular-shaped thread configured for engaging the sleeve. The male connector is unable to receive a standard female Luer fitting and the female connector is unable to engage a standard male Luer fitting.
The details of the present invention, both as to its structure and operation, can best be understood in reference to the accompanying drawings, in which like reference numerals refer to like parts, and in which:
Referring initially to
While
It is to be further understood that while the novel fluid connectors shown and described herein are illustrated in an intravascular temperature control catheter application, they can be used in other medical devices as well.
Commencing the description of the system 10 at the proximal end, as shown the exemplary non-limiting system 10 includes a heat exchange fluid source 12 that can be a water-bath heat exchange system or a TEC-based heat exchange system such as any of the systems disclosed in one or more of the above-referenced patents. Or, the source 12 can be a source of compressed gas. In any case, the heat exchange fluid source provides warmed or cooled heat exchange fluid such as saline or compressed gas through a heat exchange fluid supply line 14, and heat exchange fluid is returned to the source 12 via a heat exchange fluid return line 16. A catheter, generally designated 18, includes a source tube 20 terminating in a female fitting 22, described further below. Also, the catheter 18 has a return tube 24 terminating in a male fitting 26, also described further below. The fittings 22, 26 can be selectively engaged with complementary fittings 28, 30 (shown schematically in
With more specificity, a non-limiting catheter 18 may include a guide wire and primary infusion tube 32 that terminates in a fitting such as a standard female Luer 34. A standard male Luer 35 (shown schematically in
Moreover, a secondary infusion tube 38 with standard female Luer fitting 40 can be selectively engaged with a standard male Luer fitting 41 (shown schematically in
The source 42 may be an IV bag. Or, the source 42 may be a syringe. In any case, because the coolant line fittings 22, 26, 28, 30 cannot be engaged with standard Luers, the coolant in the source 12 cannot be erroneously connected to the infusion lines 32, 38. Likewise, for the same reason the source 42 such as a syringe cannot be erroneously engaged with the coolant lines 20, 24.
By “standard Luer” is meant a quick disconnect component, typically hard plastic, which in its male implementation has an inner cone surrounded by an outer internally threaded sleeve spaced from the cone, with the diameter at the tip of the cone being about 3.93 mm, a minimum internal thread diameter of the sleeve being about 7.00 mm, and a thread pitch being about 1.20 mm. In its female implementation a “standard Luer” is a female cone with external stub-like protrusions that act as threads and that are sized and shaped for engaging the internally threaded sleeve of the standard male Luer described above.
The tubes 20, 24, 32, 38 may be held in a distally-tapered connector manifold 44. The connector manifold 44 establishes respective pathways for fluid communication between the tubes 20, 24, 32, 38 and respective lumens in a catheter body 46.
In any case, the connector manifold 44 establishes a pathway for fluid communication between the heat exchange fluid supply tube 20 and the heat exchange fluid supply lumen of the catheter. Likewise, the connector manifold 44 establishes a pathway for fluid communication between the heat exchange fluid return tube 24 and the heat exchange fluid return lumen. Further, the connector manifold 44 establishes a pathway for fluid communication between the guide wire and primary infusion tube 32, and the guide wire lumen, which can terminate at an open distal hole 62 defined by a distally tapered and chamfered distal tip 63 of the catheter body 46. Also, the connector manifold 44 establishes a pathway for fluid communication between the secondary infusion tube 38 and the secondary infusion lumen, which can terminate at an infusion port 64 in a distal segment of the catheter body 46. Additional ports can be provided along the length of the catheter.
An exemplary non-limiting catheter 18 has a distally-located heat exchange member for effecting heat exchange with the patient when the catheter is positioned in the vasculature or rectum or other orifice of a patient. The heat exchange member can be any of the heat exchange members disclosed in the above-referenced patents. By way of example, a non-limiting catheter shown in
The heat exchange membranes 66, 68 can be inflated with heat exchange fluid from the heat exchange fluid source 12 as supplied from the heat exchange fluid supply lumen, and heat exchange fluid from the heat exchange membranes 66, 68 is returned via the heat exchange fluid return lumen to the heat exchange fluid source 12.
If desired, a temperature sensor 70 such as a thermistor or other suitable device can be attached to the catheter 18 as shown. The sensor 70 can be mounted on the catheter 18 by solvent bonding at a point that is proximal to the membranes 66, 68. Or, the sensor 70 can be disposed in a lumen of the catheter 18, or attached to a wire that is disposed in a lumen of the catheter 18, with the sensor hanging outside the catheter 18. Alternatively, a separate temperature probe can be used, such as the esophageal probe disclosed in U.S. Pat. No. 6,290,717, incorporated herein by reference. As yet another alternative, a rectal probe or tympanic temperature sensor can be used. In any case, the sensor is electrically connected to the heat exchange fluid source 12 for control of the temperature of the heat exchange fluid as described in various of the above-referenced patents.
As envisioned by the present invention, the structure set forth above can be used in many medical applications to cool a patient and/or to maintain temperature in a normothermic or hypothermic patient, for purposes of improving the medical outcomes of, e.g., cardiac arrest patients, patients suffering from myocardial infarction or stroke, etc. As another example, head trauma can be treated by and after lowering and maintaining the patient's temperature below normal body temperature. Preferably, particularly in the case of myocardial infarction, the heat exchange portions are advanced into the vena cava of the patient to cool blood flowing to the heart. The catheter can be used to keep patients warm during skin graft surgery or other surgery.
Now referring to
The male connector includes an inner hollow cone 92 that protrudes slightly beyond an outer annular sleeve 94 as shown. While referred to for simplicity as a “cone”, as can be seen from the drawing the cone 92 technically is frusto-conical. The cone 92 is spaced from the sleeve 94 so that the female connector 30 can be advanced between the sleeve 94 and cone 92 as will be described shortly. To this end, the interior of the sleeve 94 is formed with threads 96, preferably two-start threads. The sleeve 94 joins with the tube barrel 80 as shown, and gripping flanges 98 are formed lengthwise along the tube barrel 80 and sleeve 94 to assist a person in grasping and rotating the connector 26.
Turning to the female connector 30, the tube barrel 82 is hollow and frusto-conical, terminating in a ring-shaped end flange 100 that extends radially beyond the tube barrel 82 as shown. On the exterior of the flange 100, at least one and preferably radially diametrically opposed radially elongated male threads 102 are formed. In the preferred implementation a male thread 102 has a generally triangular shape; accordingly, one end 104 of the thread 102 is substantially pointed, with the male thread 102 flaring out in the axial dimension as it extends radially around the flange 100 to an opposed broad end 106 having a flat axially-oriented base 108 as shown. Like the male connector 26, the female connector 30 is formed with gripping flanges 110 that are formed lengthwise along the tube barrel 82 to assist a person in grasping and rotating the connector 30.
With the above structure, the female connector 30 can be advanced between the sleeve 94 and cone 92 of the male connector 26 while rotating the connectors 26, 30 relative to each other to engage them in an interference fit.
While the connectors 26, 30 may be engaged with each other, they may not be engaged with complementary standard Luer fittings owing in part to the structure above, e.g., the radially elongated male thread 102. Also preventing engagement of the connectors 26, 30 with standard Luer fittings are the preferred sizes and thread geometries set forth below.
Specifically and referring to
The connectors described herein may be unitary molded structures made of a plastic such as nylon, polypropylene, polyethylene, or other suitable medical plastic.
While the particular SYSTEM AND METHOD FOR EFFECTING NON-STANDARD FLUID LINE CONNECTIONS is herein shown and described in detail, it is to be understood that the subject matter which is encompassed by the present invention is limited only by the claims.
Number | Name | Date | Kind |
---|---|---|---|
4076285 | Martinez | Feb 1978 | A |
4824145 | Carlsson | Apr 1989 | A |
5207640 | Hattler | May 1993 | A |
5230862 | Berry et al. | Jul 1993 | A |
5271743 | Hattler | Dec 1993 | A |
5441487 | Vedder | Aug 1995 | A |
5450516 | Pasquali et al. | Sep 1995 | A |
5470659 | Baumgart et al. | Nov 1995 | A |
5725949 | Pasquali et al. | Mar 1998 | A |
5735809 | Gorsuch | Apr 1998 | A |
5735826 | Richmond | Apr 1998 | A |
5755690 | Saab | May 1998 | A |
5837003 | Ginsburg | Nov 1998 | A |
5876667 | Gremel et al. | Mar 1999 | A |
5879329 | Ginsburg | Mar 1999 | A |
5989238 | Ginsburg | Nov 1999 | A |
6004289 | Saab | Dec 1999 | A |
6019783 | Philips et al. | Feb 2000 | A |
6042559 | Dobak | Mar 2000 | A |
6096068 | Dobak et al. | Aug 2000 | A |
6110168 | Ginsburg | Aug 2000 | A |
6126684 | Gobin et al. | Oct 2000 | A |
6146411 | Noda et al. | Nov 2000 | A |
6149670 | Worthen et al. | Nov 2000 | A |
6149673 | Ginsburg | Nov 2000 | A |
6149676 | Ginsburg | Nov 2000 | A |
6149677 | Dobak | Nov 2000 | A |
6165207 | Balding et al. | Dec 2000 | A |
6224624 | Lasheras et al. | May 2001 | B1 |
6231594 | Dae | May 2001 | B1 |
6231595 | Dobak | May 2001 | B1 |
6235048 | Dobak | May 2001 | B1 |
6238428 | Werneth et al. | May 2001 | B1 |
6245095 | Dobak et al. | Jun 2001 | B1 |
6251129 | Dobak et al. | Jun 2001 | B1 |
6251130 | Dobak et al. | Jun 2001 | B1 |
6254626 | Dobak et al. | Jul 2001 | B1 |
6261312 | Dobak | Jul 2001 | B1 |
6264679 | Keller et al. | Jul 2001 | B1 |
6287326 | Pecor | Sep 2001 | B1 |
6290717 | Philips | Sep 2001 | B1 |
6299599 | Pham et al. | Oct 2001 | B1 |
6306161 | Ginsburg | Oct 2001 | B1 |
6312452 | Dobak et al. | Nov 2001 | B1 |
6325818 | Werneth | Dec 2001 | B1 |
6338727 | Noda et al. | Jan 2002 | B1 |
6364899 | Dobak | Apr 2002 | B1 |
6368304 | Aliberto et al. | Apr 2002 | B1 |
6379378 | Werneth et al. | Apr 2002 | B1 |
6383210 | Magers et al. | May 2002 | B1 |
6393320 | Lasersohn et al. | May 2002 | B2 |
6405080 | Lasersohn et al. | Jun 2002 | B1 |
6409747 | Gobin et al. | Jun 2002 | B1 |
6416533 | Gobin et al. | Jul 2002 | B1 |
6419643 | Shimada et al. | Jul 2002 | B1 |
6428563 | Keller | Aug 2002 | B1 |
6432124 | Worthen et al. | Aug 2002 | B1 |
6436130 | Philips et al. | Aug 2002 | B1 |
6436131 | Ginsburg | Aug 2002 | B1 |
6440158 | Saab | Aug 2002 | B1 |
6447474 | Balding | Sep 2002 | B1 |
6450987 | Kramer | Sep 2002 | B1 |
6450990 | Walker et al. | Sep 2002 | B1 |
6451045 | Walker et al. | Sep 2002 | B1 |
6454792 | Noda et al. | Sep 2002 | B1 |
6454793 | Evans et al. | Sep 2002 | B1 |
6458150 | Evans et al. | Oct 2002 | B1 |
6460544 | Worthen | Oct 2002 | B1 |
6464716 | Dobak et al. | Oct 2002 | B1 |
6468296 | Dobak et al. | Oct 2002 | B1 |
6471717 | Dobak et al. | Oct 2002 | B1 |
6475231 | Dobak et al. | Nov 2002 | B2 |
6478811 | Dobak et al. | Nov 2002 | B1 |
6478812 | Dobak et al. | Nov 2002 | B2 |
6482226 | Dobak | Nov 2002 | B1 |
6491039 | Dobak | Dec 2002 | B1 |
6491716 | Dobak et al. | Dec 2002 | B2 |
6494903 | Pecor | Dec 2002 | B2 |
6497721 | Robert et al. | Dec 2002 | B2 |
6516224 | Lasersohn et al. | Feb 2003 | B2 |
6520933 | Evans et al. | Feb 2003 | B1 |
6527798 | Ginsburg et al. | Mar 2003 | B2 |
6529775 | Whitebook et al. | Mar 2003 | B2 |
6530946 | Noda et al. | Mar 2003 | B1 |
6533804 | Dobak et al. | Mar 2003 | B2 |
6540771 | Dobak et al. | Apr 2003 | B2 |
6544282 | Dae et al. | Apr 2003 | B1 |
6551349 | Lasheras et al. | Apr 2003 | B2 |
6554797 | Worthen | Apr 2003 | B1 |
6558412 | Dobak | May 2003 | B2 |
6572538 | Takase | Jun 2003 | B2 |
6572638 | Dae et al. | Jun 2003 | B1 |
6572640 | Balding et al. | Jun 2003 | B1 |
6576001 | Werneth et al. | Jun 2003 | B2 |
6576002 | Dobak | Jun 2003 | B2 |
6581403 | Whitebook et al. | Jun 2003 | B2 |
6582398 | Worthen et al. | Jun 2003 | B1 |
6582455 | Dobak et al. | Jun 2003 | B1 |
6582457 | Dae et al. | Jun 2003 | B2 |
6585692 | Worthen | Jul 2003 | B1 |
6585752 | Dobak et al. | Jul 2003 | B2 |
6589271 | Tzeng et al. | Jul 2003 | B1 |
6595967 | Kramer | Jul 2003 | B2 |
6599312 | Dobak | Jul 2003 | B2 |
6602243 | Noda | Aug 2003 | B2 |
6602276 | Dobak et al. | Aug 2003 | B2 |
6607517 | Dae et al. | Aug 2003 | B1 |
6610083 | Keller et al. | Aug 2003 | B2 |
6620130 | Ginsburg | Sep 2003 | B1 |
6620131 | Pham et al. | Sep 2003 | B2 |
6620188 | Robert et al. | Sep 2003 | B1 |
6620189 | Machold et al. | Sep 2003 | B1 |
6623516 | Saab | Sep 2003 | B2 |
6635076 | Ginsburg | Oct 2003 | B1 |
6641602 | Balding | Nov 2003 | B2 |
6641603 | Walker et al. | Nov 2003 | B2 |
6645234 | Evans et al. | Nov 2003 | B2 |
6648906 | Lasheras et al. | Nov 2003 | B2 |
6648908 | Dobak et al. | Nov 2003 | B2 |
6652565 | Shimada et al. | Nov 2003 | B1 |
6656209 | Ginsburg | Dec 2003 | B1 |
6660028 | Magers et al. | Dec 2003 | B2 |
6673098 | Machold et al. | Jan 2004 | B1 |
6676688 | Dobak et al. | Jan 2004 | B2 |
6676689 | Dobak et al. | Jan 2004 | B2 |
6676690 | Werneth | Jan 2004 | B2 |
6679906 | Hammack et al. | Jan 2004 | B2 |
6679907 | Dobak et al. | Jan 2004 | B2 |
6682551 | Worthen et al. | Jan 2004 | B1 |
6685732 | Kramer | Feb 2004 | B2 |
6685733 | Dae et al. | Feb 2004 | B1 |
6692488 | Dobak et al. | Feb 2004 | B2 |
6692519 | Hayes | Feb 2004 | B1 |
6695873 | Dobak et al. | Feb 2004 | B2 |
6695874 | Machold et al. | Feb 2004 | B2 |
6699268 | Kordis et al. | Mar 2004 | B2 |
6702783 | Dae et al. | Mar 2004 | B1 |
6702839 | Dae et al. | Mar 2004 | B1 |
6702840 | Keller et al. | Mar 2004 | B2 |
6702841 | Nest et al. | Mar 2004 | B2 |
6702842 | Dobak et al. | Mar 2004 | B2 |
6706060 | Tzeng et al. | Mar 2004 | B2 |
6709448 | Walker et al. | Mar 2004 | B2 |
6716188 | Noda et al. | Apr 2004 | B2 |
6716236 | Tzeng et al. | Apr 2004 | B1 |
6719723 | Werneth | Apr 2004 | B2 |
6719724 | Walker et al. | Apr 2004 | B1 |
6719779 | Daoud | Apr 2004 | B2 |
6726653 | Noda et al. | Apr 2004 | B2 |
6726708 | Lasheras | Apr 2004 | B2 |
6726710 | Worthen et al. | Apr 2004 | B2 |
6730059 | Caizza et al. | May 2004 | B2 |
6733517 | Collins | May 2004 | B1 |
6740109 | Dobak | May 2004 | B2 |
6749585 | Aliberto et al. | Jun 2004 | B2 |
6749625 | Pompa et al. | Jun 2004 | B2 |
6752786 | Callister | Jun 2004 | B2 |
6755850 | Dobak | Jun 2004 | B2 |
6755851 | Noda et al. | Jun 2004 | B2 |
6796995 | Pompa | Sep 2004 | B2 |
6964406 | Doyle | Nov 2005 | B2 |
20010007951 | Dobak | Jul 2001 | A1 |
20010016764 | Dobak | Aug 2001 | A1 |
20010041923 | Dobak | Nov 2001 | A1 |
20020007203 | Gilmartin et al. | Jan 2002 | A1 |
20020016621 | Werneth et al. | Feb 2002 | A1 |
20020068964 | Dobak | Jun 2002 | A1 |
20020077680 | Noda | Jun 2002 | A1 |
20020091429 | Dobak et al. | Jul 2002 | A1 |
20020111616 | Dea et al. | Aug 2002 | A1 |
20020116039 | Walker et al. | Aug 2002 | A1 |
20020151946 | Dobak | Oct 2002 | A1 |
20020177804 | Saab | Nov 2002 | A1 |
20020183692 | Callister | Dec 2002 | A1 |
20020193738 | Adzich et al. | Dec 2002 | A1 |
20020193853 | Worthen et al. | Dec 2002 | A1 |
20020193854 | Dobak et al. | Dec 2002 | A1 |
20030078641 | Dobak | Apr 2003 | A1 |
20030114835 | Noda | Jun 2003 | A1 |
20030144714 | Dobak | Jul 2003 | A1 |
20030187489 | Dobak et al. | Oct 2003 | A1 |
20030195465 | Worthen | Oct 2003 | A1 |
20030195466 | Pham et al. | Oct 2003 | A1 |
20030195597 | Keller et al. | Oct 2003 | A1 |
20030216799 | Worthen et al. | Nov 2003 | A1 |
20030225336 | Callister et al. | Dec 2003 | A1 |
20040034399 | Ginsburg | Feb 2004 | A1 |
20040039431 | Machold et al. | Feb 2004 | A1 |
20040044388 | Pham et al. | Mar 2004 | A1 |
20040050154 | Machold et al. | Mar 2004 | A1 |
20040054325 | Ginsburg | Mar 2004 | A1 |
20040073280 | Dae et al. | Apr 2004 | A1 |
20040087934 | Dobak et al. | May 2004 | A1 |
20040102825 | Daoud | May 2004 | A1 |
20040102826 | Lasheras et al. | May 2004 | A1 |
20040102827 | Werneth | May 2004 | A1 |
20040106969 | Dobak et al. | Jun 2004 | A1 |
20040111138 | Bleam et al. | Jun 2004 | A1 |
20040116987 | Magers et al. | Jun 2004 | A1 |
20040116988 | Hammack et al. | Jun 2004 | A1 |
20040127851 | Noda et al. | Jul 2004 | A1 |
20040201216 | Segal et al. | Oct 2004 | A1 |
20040215297 | Collins | Oct 2004 | A1 |
20070076401 | Carrez | Apr 2007 | A1 |
20070158294 | Tanaka | Jul 2007 | A1 |
Number | Date | Country |
---|---|---|
09215754 | Aug 1997 | JP |
2001083001 | Nov 2001 | WO |
2004037335 | May 2004 | WO |
Entry |
---|
“Pointed”. Dictionary.com. https://www.dictionary.com/browse/pointed. Accessed Mar. 5, 2019. (Year: 2019). |
U.S. Appl. No. 60/272,442, Worthen et al. |
Number | Date | Country | |
---|---|---|---|
20170333684 A1 | Nov 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11804459 | May 2007 | US |
Child | 15483851 | US |